Three cases of acute venous thromboembolism in females after vaccination for coronavirus disease 2019.
J Vasc Surg Venous Lymphat Disord
; 10(1): 14-17, 2022 01.
Article
in English
| MEDLINE | ID: covidwho-1568905
ABSTRACT
Since December 2020, four vaccines for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) have been developed, and three have been approved for immediate use in the United States. Two are mRNA vaccines, and one uses a viral vector mechanism. Thrombotic complications have been reported after vaccine administration, which were primarily cerebral sinus thromboses after administration of the viral vector vaccines. To the best of our knowledge, we are the first to report venous thrombotic complications within days of administration of the mRNA-1273 (Moderna) vaccine. We present a series of three women who developed venous thromboembolism after RNA-1273 vaccination at a single healthcare system.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccination
/
Venous Thromboembolism
/
SARS-CoV-2
/
COVID-19
/
2019-nCoV Vaccine mRNA-1273
Type of study:
Case report
/
Diagnostic study
/
Observational study
Topics:
Vaccines
Limits:
Adult
/
Aged
/
Female
/
Humans
Language:
English
Journal:
J Vasc Surg Venous Lymphat Disord
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS